Sponsor

Royal Devon and Exeter NHS Foundation Trust

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Royal Devon and Exeter NHS Foundation Trust appears in 38 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials38
Recruiting shown5
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

38 shown
Benefits of Retained Insulin for Good HealthNCT07828626 · lead sponsor · 2025-10-31
RECRUITING
Experience of Biologic Treatments for Severe Asthma: a SurveyNCT06903780 · lead sponsor · 2025-01-01
RECRUITING
Assessing Remote Confirmation of Type 1 DiabetesNCT06821360 · lead sponsor · 2024-12-03
ENROLLING_BY_INVITATION
GUM Remote Testing v4.0NCT06244966 · lead sponsor · 2024-05-01
UNKNOWN
Laser Speckle Imaging During Breast ReconstructionNCT06523452 · lead sponsor · 2024-04-25
UNKNOWN
Day-case Endourology; Patient ExperienceNCT06152679 · lead sponsor · 2023-12-01
UNKNOWN
Evaluating ImmuNe Changes in the Evolution of Pre Type 1 Diabetes With Adult ONsetNCT06006468 · lead sponsor · 2023-02-01
COMPLETED
Adapting Body Reprogramming for Severe Asthma: a Feasibility StudyNCT04980755 · lead sponsor · 2021-07-28
COMPLETED
NEWBIE Validate: Feasibility of a New Test to Measure Glucose in Newborn Blood Spots (NBS)NCT04831723 · lead sponsor · 2021-07-09
COMPLETED
Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age.NCT04682457 · lead sponsor · 2019-11-01
COMPLETED
The Genetics of Adipose Tissue Function and Its Link to Type 2 Diabetes and Heart DiseaseNCT04040595 · lead sponsor · 2019-03-07
COMPLETED
Comparison of SITA-Standard Compared to SITA-Fast Visual Fields.NCT03192085 · lead sponsor · 2017-07-01
UNKNOWN
TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.NCT02653209 · lead sponsor · 2016-11-01
COMPLETED
StartRight: Getting the Right Classification and Treatment From Diagnosis in Adults With DiabetesNCT03737799 · lead sponsor · 2016-08-01
UNKNOWN
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) SyndromeNCT05751525 · lead sponsor · 2016-07-01
UNKNOWN
Effect of Food Composition on Postprandial Insulin Secretion in Neonatal DiabetesNCT02921906 · lead sponsor · 2016-06-01
COMPLETED
StartRIGHT: A Pilot Research Study About Diabetes Diagnosis & TreatmentNCT02287506 · lead sponsor · 2015-08-28
TERMINATED
for Adipose Tissue DIabetes VAriants (fATDIVA)NCT02505321 · lead sponsor · 2015-05-29
COMPLETED
Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 DiabetesNCT02505308 · lead sponsor · 2015-03-04
COMPLETED
Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin ProductionNCT03490773 · lead sponsor · 2014-11-01
COMPLETED
Glucose Response, Excursions And Treatment (GREAT) StudyNCT02506296 · lead sponsor · 2014-10-01
COMPLETED
RetroMASTER - Retrospective Cohort MRC ABPI STratification and Extreme Response Mechanism in DiabetesNCT02109978 · lead sponsor · 2013-04-01
COMPLETED
MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 DiabetesNCT01847144 · lead sponsor · 2013-04-01
COMPLETED
PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in DiabetesNCT02105792 · lead sponsor · 2013-03-01
COMPLETED
Predicting Response to Incretin Based Agents in Type 2 DiabetesNCT01503112 · lead sponsor · 2011-05-01
COMPLETED
GLP-1 and Microvascular Function in Type 2 DiabetesNCT01740921 · lead sponsor · 2011-01-01
COMPLETED
Obstructive Sleep Apnoea and Adipose Tissue DysfunctionNCT02518633 · lead sponsor · 2010-03-01
COMPLETED
Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 MutationsNCT00334711 · lead sponsor · 2004-01-01
COMPLETED
Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)NCT06478121 · collaborator · 2025-11-11
RECRUITING
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.NCT05102110 · collaborator · 2021-12-01
RECRUITING
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)NCT03369821 · collaborator · 2017-09-19
RECRUITING
Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 DiabetesNCT05616273 · collaborator · 2023-05-03
COMPLETED
Co-morbidity and Refractory Asthma - UK Severe Asthma RegistryNCT04553276 · collaborator · 2020-08-26
ENROLLING_BY_INVITATION
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)NCT02624830 · collaborator · 2019-02-15
UNKNOWN
Long-Term Sulfonylurea Response in KCNJ11 Neonatal DiabetesNCT02624817 · collaborator · 2015-12-01
COMPLETED
Effects of Nitrate on Liver Perfusion and Sugar ControlNCT02195856 · collaborator · 2014-07-01
COMPLETED
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R AgonistsNCT01575301 · collaborator · 2011-03-01
COMPLETED
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular ElectroporationNCT01334060 · collaborator · 2011-02-01
COMPLETED

Sponsor roles

lead sponsor28
collaborator10
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.